Effectiveness of Microneedling Combined with Topical Triamcinolone Acetonide versus Microneedling Alone in Treatment of Alopecia Areata
DOI:
https://doi.org/10.70749/ijbr.v3i6.1488Keywords:
Alopecia Areata, Triamcinolone Acetonide, Microneedling, DermoscopyAbstract
Background: Alopecia areata (AA) is a prevalent, inflammatory, non-scarring form of hair loss. The clinical presentation of AA exhibits considerable variability. Although numerous therapies are available for managing this condition, these treatment modalities yield inconsistent clinical outcomes, and there are currently no treatments that reliably induce or sustain remission. Methods: A comparative study was conducted at the Pakistan Emirates Military Hospital's Department of Dermatology from June 2024 to November 2024. The study included 40 patients aged 16 to 50 with localized alopecia areata (AA) who had not received treatment in the prior three months. Exclusions were severe AA forms, recent AA treatment, known allergies to medications, and active infections. Participants provided informed consent and were divided into two groups: Group A received microneedling combined with topical triamcinolone acetonide (10 mg/ml), and Group B received microneedling alone. Baseline and follow-up assessments included digital photography and Severity of Alopecia Tool (SALT) scoring. Data were analysed using IBM-SPSS 21.0 with statistical significance set at p ≤ 0.05. Results: The age distribution showed a mean ± SD of 32.6 ± 9.7 years for the MN + TrA group and 33.5 ± 10.4 years for the MN alone group, with a p-value of 0.09. The MN + TrA group comprised 60.0% males and 40.0% females, while the MN alone group had 25.0% males and 75.0% females (p = 0.12). Baseline SALT scores were comparable (p = 0.14). MN + TrA yielded significantly better responses, with 60.0% achieving complete recovery versus 5.0% in MN alone (p = 0.001). Side effects were minimal; irritation occurred in 5.0% of MN + TrA participants, with no significant differences in redness or scaling (p = 0.13). MN + TrA was more effective and well-tolerated than MN alone. Conclusion: Microneedling combined with topical triamcinolone acetonide are safe and effective therapeutic options for localized AA.
Downloads
References
Nikhil N, Mamatha, P, & Hanumanthayya K. (2020). A study of clinical and der-moscopic features in alopecia areata at a tertiary referral center. IntJ Res Dermatol, 6(6), 744-749.
https://doi.org/10.18203/issn.2455-4529.intjresdermatol20204457
Bertolini, M., McElwee, K., Gilhar, A., Bulfone‐Paus, S., & Paus, R. (2020). Hair follicle immune privilege and its collapse in alopecia areata. Experimental Dermatology, 29(8), 703-725.
https://doi.org/10.1111/exd.14155
Messenger, A., McKillop, J., Farrant, P., McDonagh, A., Sladden, M., Hughes, J., McLelland, J., Punjabi, S., Buckley, D., Nasr, I., Swale, V., Duarte Williamson, C., McHenry, P., Wagle, S., Amin, S., Davis, R., Haveron, S., & Mohd Mustapa, M. (2012). British association of dermatologists’ guidelines for the management of alopecia areata 2012. British Journal of Dermatology, 166(5), 916-926.
https://doi.org/10.1111/j.1365-2133.2012.10955.x
Cranwell, W. C., Lai, V. W., Photiou, L., Meah, N., Wall, D., Rathnayake, D., Joseph, S., Chitreddy, V., Gunatheesan, S., Sindhu, K., Sharma, P., Green, J., Eisman, S., Yip, L., Jones, L., & Sinclair, R. (2018). Treatment of alopecia areata: An Australian expert consensus statement. Australasian Journal of Dermatology, 60(2), 163-170.
https://doi.org/10.1111/ajd.12941
Iriarte, C., Awosika, O., Rengifo-Pardo, M., & Ehrlich, A. (2017). Review of applications of microneedling in dermatology. Clinical, Cosmetic and Investigational Dermatology, 10, 289-298.
https://doi.org/10.2147/ccid.s142450
Mysore, V., Chandrashekar, B., & Yepuri, V. (2014). Alopecia areata-successful outcome with microneedling and triamcinolone acetonide. Journal of Cutaneous and Aesthetic Surgery, 7(1), 63.
https://doi.org/10.4103/0974-2077.129989
Fertig, R., Gamret, A., Cervantes, J., & Tosti, A. (2017). Microneedling for the treatment of hair loss? Journal of the European Academy of Dermatology and Venereology, 32(4), 564-569.
https://doi.org/10.1111/jdv.14722
Mustafa, A. I., Khashaba, R. A., Fawzy, E., Baghdady, S. M., & Rezk, S. M. (2020). Cross talk between oxidative stress and inflammation in alopecia areata. Journal of Cosmetic Dermatology, 20(7), 2305-2310.
https://doi.org/10.1111/jocd.13814
Pourang, A., & Mesinkovska, N. A. (2020). New and emerging therapies for alopecia Areata. Drugs, 80(7), 635-646.
https://doi.org/10.1007/s40265-020-01293-0
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., ... & Kim, H. (2013). Allergy Asthma Clin. Immunol, 9, 30.
Messenger, A., McKillop, J., Farrant, P., McDonagh, A., Sladden, M., Hughes, J., McLelland, J., Punjabi, S., Buckley, D., Nasr, I., Swale, V., Duarte Williamson, C., McHenry, P., Wagle, S., Amin, S., Davis, R., Haveron, S., & Mohd Mustapa, M. (2012). British association of dermatologists’ guidelines for the management of alopecia areata 2012. British Journal of Dermatology, 166(5), 916-926.
https://doi.org/10.1111/j.1365-2133.2012.10955.x
Kumaresan, M. (2010). Intralesional steroids for alopecia areata. International Journal of Trichology, 2(1), 63.
https://doi.org/10.4103/0974-7753.66920
Fertig, R., Gamret, A., Cervantes, J., & Tosti, A. (2017). Microneedling for the treatment of hair loss? Journal of the European Academy of Dermatology and Venereology, 32(4), 564-569.
https://doi.org/10.1111/jdv.14722
Aboeldahab, S., Nada, E. E., Assaf, H. A., Gouda, Z. A., & Abu El‐Hamd, M. (2021). Superficial cryotherapy using dimethyl Ether and propane mixture versus microneedling in the treatment of alopecia areata: A prospective single‐blinded randomized clinical trial. Dermatologic Therapy, 34(5).
https://doi.org/10.1111/dth.15044
Giorgio, C. M., Babino, G., Caccavale, S., Russo, T., De Rosa, A. B., Alfano, R., Fulgione, E., & Argenziano, G. (2019). Combination of photodynamic therapy with 5‐aminolaevulinic acid and microneedling in the treatment of alopecia areata resistant to conventional therapies: Our experience with 41 patients. Clinical and Experimental Dermatology, 45(3), 323-326.
https://doi.org/10.1111/ced.14084
Chandrashekar, B. S., Sandeep, M. A., Vasanth, V., & Rajashekar, M. L. (2015). Triamcinolone acetonide mesotherapy in the treatment of recalcitrant patches of alopecia areata—a pilot study. J Clin Dermatol Ther, 2(1), 1-4.
https://doi.org/10.24966/cdt-8771/100006
Mysore, V., Chandrashekar, B., & Yepuri, V. (2014). Alopecia areata-successful outcome with microneedling and triamcinolone acetonide. Journal of Cutaneous and Aesthetic Surgery, 7(1), 63.
https://doi.org/10.4103/0974-2077.129989
Farid, C. I., & Abdelmaksoud, R. A. (2016). Platelet-rich plasma microneedling versus 5% topical minoxidil in the treatment of patterned hair loss. Journal of the Egyptian Womenʼs Dermatologic Society, 13(1), 29-36.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
